Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 42 0.92 (2.24%) Market Cap: 2.00 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 8.72 GF Score: 52/100

Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 10:20PM GMT
Release Date Price: $20.42 (+5.04%)
Christopher Peetz
Mirum Pharmaceuticals, Inc. - President, CEO & Director

Hello, and welcome -- sorry. Go ahead, Kat.

Katja Lange
JPMorgan Chase & Co. - Executive Director in healthcare coverage team

Yes. I'll do this real quick, and then I'll pass it over to you. So good afternoon, everyone. Thank you for joining us. My name is Kat Lange. I'm a member of the health care investment banking team here at JPMorgan. It's a great pleasure to have Mirum Pharma join us here today for our presentation.

So just a real quick reminder, we will be doing a Q&A session at the end of this. (Operator Instructions)

And with that, I'd like to hand it over to Chris Peetz, Founder and CEO of Mirum Pharma.

Christopher Peetz
Mirum Pharmaceuticals, Inc. - President, CEO & Director

Thanks, Kat, and thanks, everyone, for your interest in Mirum today. Excited to tell you about our programs and an update on the company that we gave this morning. Today, I'll be making some forward-looking statements. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot